Original news and analysis on international IP policy
The World Health Organization has been soul-searching for several years since running into deep debt and seeing private organisations gather influence in global public health policy. Next week, the WHO Board will consider a proposal on how to allow the intergovernmental body work with such organisations and industry without giving up its own independence and oversight role.
DG Shah writes: Acquisition of brownfield, or existing, pharmaceutical companies may be seen in different perspectives as greenfield, or new, projects are permitted 100% equity via the automatic route. India has sought FDI mainly to bridge the shortfall in investment or to facilitate the flow of know-how and technology. We must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.
2013 was an awkward year in the United States for so-called “patent trolls.” These companies, whose primary business is monetising their patents through licensing and litigation, faced growing criticism from academics, business executives, and US government officials. 2014 could prove even worse for trolls: America’s Congress, courts and executive branch are now considering various measures that would make patent trolling more difficult. And those are just some of the major changes that are likely to roil the US IP system this year.
Looking back on 2013, the list of the most-viewed stories on the Intellectual Property Watch website shows that reporting on activities in India, especially related to patents and public health, continued to draw the most attention. Other top stories were the Marrakesh Treaty on copyright exceptions for blind readers, legal cases involving patents on seeds and on plant and human genes, the election for World Intellectual Property Organization director general, free-trade agreements (including the Wikileaks leak of the IP chapter of the Trans-Atlantic Partnership agreement), Russian copyrights, and 3D printing.
The State Intellectual Property Office of China (SIPO) has a new commissioner, Shen Changyu. And the World Intellectual Property Organization wasted no time in meeting with him. China was approved last month to receive a new WIPO office.
An upcoming conference in Mumbai, India will look at patent laws related to the pharmaceutical and biopharma industries regionally and internationally.
CPhI's 3rd Annual Pharma IPR 2014, taking place from 26-28 February, is a targeted conference focusing on patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies.
The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in the EU; and formulating strategies to introduce generic products in international markets.
The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries.
Click here to view the region-wise agenda.
Free download for IP-Watch Readers! Click here to view presentations from 2013!
A recent conference on intellectual property and the public interest concluded with the adoption of public interest principles to guide international trade negotiations and international organisations.
After a week of work on the three current subjects of the World Intellectual Property Organization copyright committee, member states mostly made progress on a potential treaty to protect broadcasting organisations, while exceptions and limitations to copyright for libraries, archives, education and research remain in the stage of determining broad concepts.
The World Intellectual Property Organization will hold a conference in January on open innovation and the future of knowledge, featuring some surprising speakers.
When it comes to software-related inventions, US patent law is a confused mess. So it was no surprise that, in early December, the United States Supreme Court announced it would weigh in on the matter. The court granted certiorari in Alice Corporation v. CLS Bank in order to decide when software-related inventions are patentable subject matter. But given the complicated technology and the high court’s confusing precedents in this area, many experts fear that the ruling in Alice will bring little clarity to this area of the law.
A new private-sector report shows that after a downturn, patents on a range of technologies for water are back on the rise as companies are busy innovating around a basic human need and resource.
The new National Academies report on patents and standards is a landmark effort to shed light on the tensions between patents and standards in information and communications technology. Brian Kahin critiques the report and examines underlying problems that the report sidesteps.